Side effects of topical glucocorticoids.
Mills
C M
CM
Department of Dermatology, University Hospital of Wales, Cardiff, UK.
Marks
R
R
D000279:Administration, Cutaneous; D000328:Adult; D001284:Atrophy; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000009:adverse effects; D001706:Biopsy; D002452:Cell Count / Q000187:drug effects; D002990:Clobetasol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D004341:Drug Evaluation; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects* / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D015603:Keratinocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings; D014677:Pharmaceutical Vehicles; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D012867:Skin / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D013684:Telangiectasis / Q000139:chemically induced; D014463:Ultrasonography
D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles; C007975:hydrocortisone-17-butyrate; D001624:Betamethasone Valerate; D011239:Prednisolone; D002990:Clobetasol; C035287:prednicarbate; D006854:Hydrocortisone